PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
PRO DEX INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 3, 2026
$57.70−0.56 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $193.98M
- P/E (TTM)
- 14.0
- Dividend yield
- –
Share price
+$31.48 (+120.1%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
PRO DEX INC grew revenue 16.5% to $77.55M over the twelve months to Jun 30, 2026. Operating income rose 21.5% to $12.99M, moving the operating margin from 16.1% to 16.8%. Free cash flow was $6.76M.
Revenue
$77.55M
+16.5% vs. a year earlier
Operating income
$12.99M
+21.5% vs. a year earlier
Free cash flow
$6.76M
TTM Q4 2026
EPS, diluted
$4.12
+54.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $193.98M
- P/E ratio
- 14.0
- Price to sales
- 2.50
- Price to book
- 4.07
- Dividend yield
- –
- Free cash flow yield
- 3.48%
Fundamentals
- Revenue
- $77.55M
- Net income
- $13.66M
- EPS, diluted
- $4.12
- Free cash flow
- $6.76M
- Book value per share
- $14.17
- Diluted shares
- 3M
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Revenue
$77.55M+16.5% YoY
Gross profit
$24.34M+24.7% YoY
Operating income
$12.99M+21.5% YoY
Net income
$13.66M+52.2% YoY
EPS, diluted
$4.12+54.3% YoY
Free cash flow
$6.76M
Reported period